| Primary |
| Precursor B-lymphoblastic Lymphoma |
42.1% |
| B Precursor Type Acute Leukaemia |
36.8% |
| T-cell Lymphoma |
21.1% |
|
| Posterior Reversible Encephalopathy Syndrome |
33.3% |
| Transaminases Increased |
33.3% |
| Venoocclusive Liver Disease |
33.3% |
|
| Secondary |
| Acute Lymphocytic Leukaemia |
20.3% |
| Acute Myeloid Leukaemia |
18.7% |
| Drug Use For Unknown Indication |
17.1% |
| Chronic Myeloid Leukaemia |
8.7% |
| Infection Prophylaxis |
4.2% |
| Myelodysplastic Syndrome |
4.2% |
| Non-hodgkin's Lymphoma |
3.8% |
| Precursor B-lymphoblastic Lymphoma |
3.2% |
| Prophylaxis |
3.0% |
| Product Used For Unknown Indication |
2.2% |
| Hypertension |
2.0% |
| Lymphoma |
2.0% |
| Myelofibrosis |
1.6% |
| T-cell Lymphoma |
1.6% |
| B Precursor Type Acute Leukaemia |
1.4% |
| Febrile Neutropenia |
1.4% |
| Insomnia |
1.2% |
| Oesophageal Squamous Cell Carcinoma |
1.2% |
| Depression |
1.0% |
| Fungal Infection |
1.0% |
|
| White Blood Cell Count Decreased |
18.9% |
| Venoocclusive Liver Disease |
9.4% |
| Drug Toxicity |
5.7% |
| Pancreatitis |
5.7% |
| Shock |
5.7% |
| Vasculitis |
5.7% |
| Anaphylactic Shock |
3.8% |
| Azoospermia |
3.8% |
| Joint Swelling |
3.8% |
| Nausea |
3.8% |
| Neutrophil Count Decreased |
3.8% |
| Organising Pneumonia |
3.8% |
| Pneumonia |
3.8% |
| Pneumonitis |
3.8% |
| Pneumothorax |
3.8% |
| Sick Sinus Syndrome |
3.8% |
| Thrombocytopenic Purpura |
3.8% |
| Tonic Clonic Movements |
3.8% |
| Aplasia |
1.9% |
| Blood Creatinine Increased |
1.9% |
|
| Concomitant |
| Neoplasm Malignant |
17.2% |
| Acute Lymphocytic Leukaemia |
15.4% |
| Drug Use For Unknown Indication |
11.1% |
| Infection Prophylaxis |
9.4% |
| Febrile Neutropenia |
7.8% |
| Prophylaxis |
5.1% |
| Sepsis |
4.6% |
| Premedication |
3.8% |
| Multiple Myeloma |
3.5% |
| Fungal Infection |
3.3% |
| Precursor T-lymphoblastic Lymphoma/leukaemia |
3.0% |
| Chemotherapy |
2.5% |
| T-cell Prolymphocytic Leukaemia |
2.5% |
| Acute Myeloid Leukaemia |
2.0% |
| Pain |
2.0% |
| Chronic Myeloid Leukaemia |
1.5% |
| Hepatitis C |
1.5% |
| B Precursor Type Acute Leukaemia |
1.3% |
| Prophylactic |
1.3% |
| Acute Myeloblastic Leukaemia |
1.0% |
|
| Restlessness |
10.9% |
| Tremor |
10.9% |
| White Blood Cell Count Decreased |
9.1% |
| Renal Disorder |
7.3% |
| Pneumonia |
5.5% |
| Sepsis |
5.5% |
| Septic Shock |
5.5% |
| Neuropathy Peripheral |
3.6% |
| No Therapeutic Response |
3.6% |
| Pancreatitis Acute |
3.6% |
| Pneumonia Legionella |
3.6% |
| Pyrexia |
3.6% |
| Respiratory Disorder |
3.6% |
| Skin Lesion |
3.6% |
| Stomatitis |
3.6% |
| Upper Gastrointestinal Haemorrhage |
3.6% |
| Venous Thrombosis |
3.6% |
| Vomiting |
3.6% |
| Weight Increased |
3.6% |
| Blood Creatinine Increased |
1.8% |
|
